Koyfin Home > Directory > Health Care > Amicus Therapeutics > Preferred Equity

Amicus Therapeutics Preferred Equity Chart (FOLD)

Amicus Therapeutics annual/quarterly Preferred Equity from 2006 to 2007.
  • Amicus Therapeutics Preferred Equity for the quarter ending March 03, 2007 was $148m
  • Amicus Therapeutics Preferred Equity for the last 12 months ending March 03, 2007 was $148m a 59.19% increase of 88m year over year
  • Amicus Therapeutics Annual Preferred Equity for 2006 was $124m a 51.27% increase of 64m from 2005
  • Amicus Therapeutics Annual Preferred Equity for 2005 was $60m a 66.90% increase of 40m from 2004
  • Amicus Therapeutics Annual Preferred Equity for 2004 was $20m
Other Balance Sheet Metrics:
  • Amicus Therapeutics Total Assets for the quarter ending September 09, 2018 was $839m a 25.23% increase of 212m year over year
  • Amicus Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $39m a -4.44% decrease of -2m year over year
  • Amicus Therapeutics Total Equity for the quarter ending September 09, 2018 was $411m a 14.14% increase of 58m year over year
View Chart On Koyfin

Quarterly FOLD Preferred Equity Data

03/2007$148m
12/2006$124m
03/2006$61m

Annual FOLD Preferred Equity Data

2006$124m
2005$60m
2004$20m